VYNE icon

VYNE Therapeutics

38 hedge funds and large institutions have $11.5M invested in VYNE Therapeutics in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+3
Holders Change %
+8.57%
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
15
Reduced
7
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
SC
26
Shay Capital
New York
$28.5K +$28.5K +18,015 New
Bank of America
27
Bank of America
North Carolina
$27.1K +$24.8K +15,672 +1,051%
State Street
28
State Street
Massachusetts
$24.9K
Morgan Stanley
29
Morgan Stanley
New York
$20.2K +$13.4K +8,512 +198%
UBS Group
30
UBS Group
Switzerland
$12K +$11K +6,945 +1,101%
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
$9.45K +$8.95K +5,667 +1,805%
TRCT
32
Tower Research Capital (TRC)
New York
$6.79K +$4.6K +2,910 +210%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$4K -$37.4K -22,789 -90%
MLA
34
MB, Levis & Associates
Pennsylvania
$1.65K
Carson Wealth (CWM LLC)
35
Carson Wealth (CWM LLC)
Nebraska
$1K
CA
36
Centerpoint Advisors
Massachusetts
$1K
Wells Fargo
37
Wells Fargo
California
$103
TC
38
Truvestments Capital
Florida
$40 +$40 +25 New
CAM
39
Cormorant Asset Management
Massachusetts
-$4.67M -1,394,336 Closed
Jane Street
40
Jane Street
New York
-$68K -20,286 Closed
BL
41
BFSG LLC
California
-$11.7K -3,500 Closed
Fidelity Investments
42
Fidelity Investments
Massachusetts
-$17 -5 Closed